| Ytd | -71.02% | |
| 1y | -79.19% |
| Open | 4.80 | Prev Close | 5.32 | Low | 5.28 | High | 5.52 | Mkt Cap | 8.11M |
| Vol | 236.85K | Avg Vol | 7.89K | EPS | -46.59 | P/E | -0.11 | Forward P/E | -0.59 |
| Beta | 0.68 | Short Ratio | 2.20 | Inst. Own | 28.16% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | 15.21 | 200-d Avg | 12.80 | 1yr Est | 1.01 |
CARA News
Merger creates a Nasdaq-listed, clinical-stage biopharmaceutical company – Tvardi Therapeutics – dev
STAMFORD, Conn., April 14, 2025 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq: CARA) (the “Com
NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and th
NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and th
STAMFORD, Conn., Dec. 27, 2024 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq: CARA) (the “ Com
Alessia's fans will experience a behind-the-scenes look at the creative process for her Love & Hyper
NEW YORK , Dec. 18, 2024 /PRNewswire/ -- Monteverde & Associates PC (the "M&A Class Action Firm"), h
MILWAUKEE--(BUSINESS WIRE)--Ademi LLP is investigating Cara (NASDAQ: CARA) for possible breaches of
Proposed Merger to create a Nasdaq-listed, clinical-stage biopharmaceutical company developing novel
Shares of Cara Therapeutics Inc CARA tanked in early trading on Thursday, with the Dow shedding more
Cara Therapeutics (NASDAQ: CARA ) stock is falling hard on Thursday after the development-stage biop
Cara Therapeutics said on Wednesday it will discontinue a mid-to-late stage study for a neurological
– Oral difelikefalin did not demonstrate meaningful clinical benefit compared to placebo – – Company
Cara Therapeutics (CARA) came out with a quarterly loss of $0.56 per share versus the Zacks Consensu
Topline efficacy and safety results from KOURAGE 1 Part A portion of notalgia paresthetica (NP) pivo
STAMFORD, Conn., May 06, 2024 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq: CARA), a developm
Cara Therapeutics, Inc. (Nasdaq: CARA), a development-stage biopharmaceutical company leading a new
STAMFORD, Conn., April 02, 2024 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq: CARA), a develo
STAMFORD, Conn., March 07, 2024 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq: CARA), a develo
Cara Therapeutics, Inc. (NASDAQ:CARA ) Q4 2023 Earnings Call Transcript March 4, 2024 4:30 PM ET Com
Companies Reporting Before The Bell • Sohu.com (NASDAQ:SOHU) is expected to report earnings for its
On Tuesday, 164 companies achieved new lows for the year.
On Friday, 469 companies hit new 52-week lows.
On Wednesday, 479 stocks made new 52-week lows.
On Wednesday, 116 companies set new 52-week lows.
Gainers Virax Biolabs Group Limited (NASDAQ: VRAX) jumped 99% to $1.3195 after the company announ
Gainers
On Friday, 1043 companies hit new 52-week lows.
Stocks That Hit 52-Week Lows On Monday
Stocks That Hit 52-Week Lows On Thursday
Stocks That Hit 52-Week Lows On Friday